03:40 PM EST - Valeant Pharmaceuticals International : Reports its wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, and IBM today announced a collaboration to develop the first app of its kind for iPhone and iPad to assist surgeons who perform cataract surgery. Valeant Pharmaceuticals International
shares T.VRX are trading down $0.22 at $44.51.
